Try The Drug Club risk-free for 30 days Trial terms

Calcipotriene — Membership Pricing

Calcipotriene is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Calcipotriene Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$66.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Calcipotriene

Calcipotriene is a prescription medication. Ask your doctor if Calcipotriene is right for you.

Other strengths and forms of Calcipotriene

Conditions Treated with Calcipotriene

How to Check Calcipotriene Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Calcipotriene at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Psoriasis

Also listed for Psoriasis (Mild–Moderate)

Other medications in Dermatology

What Calcipotriene is approved for (FDA label)

Calcipotriene ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Source: Read the full FDA label on DailyMed. Label effective date: July 14, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Calcipotriene (FDA label)

In controlled clinical trials, the most frequent adverse reactions reported for calcipotriene were burning, itching and skin irritation, which occurred in approximately 10-15% of patients. Erythema, dry skin, peeling, rash, dermatitis, worsening of psoriasis including development of facial/scalp psoriasis were reported in 1 to 10% of patients. Other experiences reported in less than 1% of patients included skin atrophy, hyperpigmentation, hypercalcemia, and folliculitis. Once daily dosing has not been shown to be superior in safety to twice daily dosing.

Source: FDA prescribing information (DailyMed). Set ID: 277d843a-0ea9-429d-813d-49ed72dafb64. SPL document ID: 5698a2a4-f8fb-0b4b-e063-6394a90ab60c. Label effective date: July 14, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Calcipotriene (FDA label)

Calcipotriene is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. It should not be used by patients with demonstrated hypercalcemia or evidence of vitamin D toxicity. Calcipotriene should not be used on the face.

Source: FDA prescribing information (DailyMed). Set ID: 277d843a-0ea9-429d-813d-49ed72dafb64. SPL document ID: 5698a2a4-f8fb-0b4b-e063-6394a90ab60c. Label effective date: July 14, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial